Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 22nd PKPD Expertentreffen in the heart of the Black Forest 3rd GBHI in Amsterdam: lively discussions and intensive exchange with authorities Meet us in Amsterdam: 3rd GBHI Conference starts soon (12 – 13 April 2018) Meet us in Munich: AGAH Annual Meeting 26 – 27 April 2018 Regorafenib: first in human as eye drops 3rd GBHI conference – all speakers confirmed Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Drug Food Interaction Auditing TTS Protocol Phase IV Rhine Main area Recruitment rates Immunogenicity GCP Phase III Female adolescents Protocol development IMPD Biopharmaceutics Standardisation Dry eye SDV Dermal irritation Charcoal Central surveillance system Clinical pharmacology unit Phase I Legal Information Sensitisation trials Statistical services Biosimilars EMA SAS Audit DPI Referral system Monitoring IVIVC Safety CDSIC WinNonlin Data management Project Management Pharmacokintetics Ophthalmologist SOP based Absorption windows ANVISA IB Pragmatism HTA NIS Steady state Centralised procedure Local tolerability First in human Inhalatives Asthma Efficacy Design development Metered dose inhaler CDISC Creativity Patients PASS CDASH Contraception Clinical Monitoring FIM COPD DDI FDA PAES Life cycle management Network Cough ICF Glaucoma Drug Drug Interaction ADAM Copyright Informed Consent Procedure Pituitary Pilot study Database MDI Anaesthesiologist Highly variable drugs US CFR 21 Part 11 Bioequivalence Cardiovascular surveillance DUS Inspection Common cold Pharmacokinetics Experience CDM Ovulation inhibition Paediatricians Slit lamp microscopy Biopharmaceutical MCID Sore throat Quality Management System Elpro Adrenocortical Hormone replacement therapy Xerostomia Ophthalmological trials IEC Edema Dry powder inhaler Clinical trials Gynaecological trials Phase IIa trials Pulse oximetry plethysmography Spacious archive Transdermal therapeutic system Quality Lung Ocular tolerability Legal representative Sample size estimation Dose linearity Biometrics Statistical Analysis Plan Patient recruitment Uveitis Macular Authorities Clinical study CRA Absorption DFI AGAH Children Good Clinical Practice Statistical programming Non interventional Source Data Verification Product development Oncology In vitro in vivo correlation Intensive assessment station HPA axis Phase II OTC Competence Phase I Unit Scientific advice Subcontractor qualification GLP MMM Axis Expert Hypothalamic Eye disease Phase IIb trials Data Validation Plan Healthy subjects Scientific expertise Pharmacology Data Management Plan Patch Pharmacodynamic studies Thuringia US FDA Oncological patients Endpoint Sequential designs Consultancy Post authorisation CRF Ophthalmology Postmenopausal women Early phase Allergy SocraTec C&S Patch adhesion Feasibility Training GCP training Bioavailability Clinical development program Oncologic network Investigators brochure Degeneration Standard operating procedure Quality Assurance HRT CRO  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page